Intervention of interest:

  • Mepolizumab (Nucala®, GlaxoSmithKline plc.)

An estimated 22 million Americans have asthma, which causes the airways of the lungs to narrow or become blocked, making it hard to breathe. Among both young and old, asthma can have a significant impact on health and limit the ability to pursue many activities.

For questions, contact info@icer.org.


Final Documents

Below you will find the final documents from the assessments review process:

Public Comments on Draft Evidence ReportDownload
Response to Public CommentsDownload
Report-at-a-Glance (English)Download
Report-at-a-Glance (Spanish)Download
Final Evidence Report and Meeting SummaryDownload